Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults-Reference-Cited by-同舟云学术

Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults

Published:2022-03 Issue: Volume:28 Page:67-70
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Esquivel Marc D.,Monogue Marguerite L.^ORCID,Smith Greg S.,Finklea James D.^ORCID,Sanders James M.

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference13 articles.

1. Cystic Fibrosis Foundation. 2020 Patient Registry Annual Data Report. https://www.cff.org/medical-professionals/patient-registry [accessed 10 January 2022].

2. Structure and function of the CFTR chloride channel;Sheppard;Physiol Rev,1999

3. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis;Dasenbrook;JAMA,2010

4. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function;Ren;Pediatr Pulmonol,2007

5. Comparative effectiveness of vancomycin versus linezolid for the treatment of acute pulmonary exacerbations of cystic fibrosis;Fusco;Ann Pharmacother,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?;Frontiers in Medicine;2023-05-17

2. Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance;Annals of Pharmacotherapy;2022-03-18